Results 11 to 20 of about 313,394 (308)
Botanicals in Postmenopausal Osteoporosis [PDF]
Nutrients, 2021 Osteoporosis is a systemic bone disease characterized by reduced bone mass and the deterioration of bone microarchitecture leading to bone fragility and an increased risk of fractures.
W. Słupski, P. Jawień, B. Nowak
semanticscholar +3 more sources
Postmenopausal osteoporosis. [PDF]
BMJ, 1982 It is the responsibility of nurses to be informed about osteoporosis, especially about measures which may protect against rapid and early bone loss, and to share this knowledge with patients. The role of the nurse is to educate: to present known data about diet, exercise, and calcium and vitamin D supplementation.
J C, Stevenson, M I, Whitehead
openaire +4 more sources
Nature Reviews Disease Primers, 2016 Osteoporosis is a metabolic bone disorder that is characterized by low bone mass and micro-architectural deterioration of bone tissue. Fractures of the proximal femur, the vertebrae and the distal radius are the most frequent osteoporotic fractures, although most fractures in the elderly are probably at least partly related to bone fragility.
Eastell, Richard +6 more
+15 more sources
Postmenopausal osteoporosis coexisting with sarcopenia: the role and mechanisms of estrogen.
Journal of Endocrinology, 2023 Estrogens (estradiol, estriol, and estrone) are important hormones that directly and indirectly regulate the metabolism and function of bone and skeletal muscle via estrogen receptors.
Lingyun Lu, L. Tian
semanticscholar +1 more source
Frontiers in Endocrinology, 2023 Aim To explore the risk factors of osteoporosis in postmenopausal women in China. Method This study collected all patient data from January 2014 to December 2015.
Guo Tang +5 more
semanticscholar +1 more source
Identification of miR-194-5p as a potential biomarker for postmenopausal osteoporosis [PDF]
PeerJ, 2015 The incidence of osteoporosis is high in postmenopausal women due to altered estrogen levels and continuous calcium loss that occurs with aging. Recent studies have shown that microRNAs (miRNAs) are involved in the development of osteoporosis.
Jia Meng +8 more
doaj +2 more sources
Hypercalciuria in Postmenopausal Osteoporosis [PDF]
, 2004 Women aged between 35 to 75, termed as postmenopausal at least for one year, not smoking and not drinking alcohol, not using any medicine related with menopause and osteoporosis made up our patient and control groups.
Hale Aral +3 more
core +3 more sources
Frontiers in Endocrinology, 2021 BackgroundPsychological stress is associated with postmenopausal osteoporosis. However, the underlying mechanism of stress-related brain neural activity with osteoporosis is not fully elucidated.
Kisoo Pahk +3 more
doaj +1 more source
Diabetology & Metabolic Syndrome, 2023 Background Studies on the association of gestational diabetes mellitus (GDM) with osteoporosis, and bone mineral density (BMD) have been inconsistent.
Boqi Lu, Liping Zhang
doaj +1 more source
Interaction between bone and immune cells: Implications for postmenopausal osteoporosis.
Seminars in Cell and Developmental Biology, 2021 Postmenopausal osteoporosis is a systemic disease characterized by the loss of bone mass and increased bone fracture risk largely resulting from significantly reduced levels of the hormone estrogen after menopause.
V. Fischer, M. Haffner-Luntzer
semanticscholar +1 more source